Publication

HOME > Publication > Publication 2013
Publication 2013
  1. Yamamoto Y, Izumikawa K, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Tsukamoto M, Kakeya H, Yanagihara K, Yasuoka A, Kohno S: Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan. J Infect Chemother. 19: 291-298, 2013
  2. Kohno S, Izumikawa K, Yoshida M, Takesue Y, Oka S, Kamei K, Miyazaki Y, Yoshinari T, Kartsonis NA, Niki Y: A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis. Eur J Clin Microbiol Infect Dis. 32: 387-397, 2013
  3. Hosogaya N, Miyazaki T, Nagi M, Tanabe K, Minematsu A, Nagayoshi Y, Yamauchi S, Nakamura S, Imamura Y, Izumikawa K, Kakeya H, Yanagihara K, Miyazaki Y, Kugiyama K, Kohno S: The heme-binding protein Dap1 links iron homeostasis to azole resistance via the P450 protein Erg11 in Candida glabrata. FEMS Yeast Res. 13: 411-421, 2013
  4. Nagaoka K, Yanagihara K, Harada Y, Yamada K, Migiyama Y, Morinaga Y, Hasegawa H, Izumikawa K, Kakeya H, Nishimura M, Kohno S: Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells. Antimicrob Agents Chemother. 57: 1844-1849, 2013
  5. Mihara T, Izumikawa K, Kakeya H, Ngamskulrungroj P, Umeyama T, Takazono T, Tashiro M, Nakamura S, Imamura Y, Miyazaki T, Ohno H, Yamamoto Y, Yanagihara K, Miyazaki Y, Kohno S: Multilocus sequence typing of Cryptococcus neoformans in non-HIV associated cryptococcosis in Nagasaki, Japan. Med Mycol. 51: 252-260, 2013
  6. Harada Y, Yanagihara K, Yamada K, Migiyama Y, Nagaoka K, Morinaga Y, Nakamura S, Imamura Y, Hasegawa H, Miyazaki T, Izumikawa K, Kakeya H, Kohno S: In vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of hematogenous pulmonary infection. Antimicrob Agents Chemother. 57: 2841-2844, 2013
  7. Tanaka A, Nakamura S, Seki M, Fukudome K, Iwanaga N, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Yanagihara K, Kohno S: Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae. Clin Vaccine Immunol. 20: 977-985, 2013
  8. Kaku N, Yanagihara K, Morinaga Y, Izumikawa K, Nagashima S, Kakeya H, Yamamoto Y, Fukuda M, Takatani H, Fukuda M, Hashiguchi K, Kohno S: The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP). J Infect Chemother. 19: 70-76, 2013
  9. Migiyama Y, Kaneko Y, Yanagihara K, Morohoshi T, Morinaga Y, Nakamura S, Miyazaki T, Hasegawa H, Izumikawa K, Kakeya H, Kohrogi H, Kohno S: Efficacy of AiiM, an N-acylhomoserine lactonase, against Pseudomonas aeruginosa in a mouse model of acute pneumonia. Antimicrob Agents Chemother. 57: 3653-3658, 2013
  10. Yamada K, Yanagihara K, Kaku N, Harada Y, Migiyama Y, Nagaoka K, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Hasegawa H, Mikamo H, Kohno S: Azithromycin attenuates lung inflammation in a mouse model of ventilator associated pneumonia by multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother.  57: 3883-3888, 2013
  11. Iwanaga N, Fukuda Y, Nakamura S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Yanagihara K, Soda H, Tashiro T, Kohno S: Necrotizing pneumonia due to femoral osteomyelitis caused by community-acquired methicillin-resistant Staphylococcus aureus. Intern Med. 52: 1531-1536, 2013
  12. Tashiro T, Izumikawa K, Tashiro M, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Yamamoto Y, Yanagihara K, Hayashi T, Nagayasu T, Kohno S: A case series of chronic necrotizing pulmonary aspergillosis and a new proposal. Jpn J Infect Dis. 66: 312-316, 2013
  13. Yamada K, Yanagihara K, Kaku N, Harada Y, Migiyama Y, Nagaoka K, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Hasegawa H, Yasuoka A, Kohno S. In vivo efficacy of biapenem with ME1071, a novel metallo-β-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa. Int J Antimicrob Agents. 42: 238-243, 2013
  14. Takazono T, Izumikawa K, Suyama N, Kohno S. Cavitary pulmonary metastases and aspergillosis: an autopsy case. Intern Med. 52: 1751-1752, 2013
  15. Morinaga Y, Yanagihara K, Gyotoku H, Oshima K, Izumikawa K, Yamasaki N, Kakeya, H, Hayashi T, Fukuoka J, Nagayasu T, Kohno S: Pulmonary artery pseudoaneurysm caused by Streptococcus constellatus. Int J Infect Dis 17: e1064-1066, 2013
  16. Nagaoka K, Yanagihara K, Harada Y, Yamada K, Migiyama Y, Morinaga Y, Izumikawa K, Kakeya H, Nakashima M, Nishimura M, Kohno S: Establishment of a new murine model of liver abscess induced by Fusobacterium necrophorum injected into the caudal vein. J Med Microbiol 62: 1755-1759, 2013
  17. Harada Y, Morinaga Y, Yamada K, Migiyama Y, Nagaoka K, Uno N, Nakamura S, Imamura Y, Miyazaki T, Hasegawa H, Izumikawa K, Kakeya H, Yanagihara K, Kohno S: Clinical and Molecular Epidemiology of Extended-Spectrum β-lactamase- Producing Klebsiella pneumoniae and Escherichia Coli in a Japanese Tertiary Hospital. J Med Microb Diagn 2: 3, 2013
  18. Miyazaki T, Nakayama H, Nagayoshi Y, Kakeya H, Kohno S: Dissection of Ire1 functions reveals stress response mechanisms uniquely evolved in Candida glabrata. PLoS Pathog. 9(1): e1003160, 2013

(Presentations)

  1. 23rd ECCMID Morinaga Y, Yanagihara K, Kaku N, Harada Y, Migiyama Y, Nagaoka K, Hasegawa H, Izumikawa K, Kakeya H and Kohno S: The characteristics of experimentally-induced MRSA small colony variants from clinical blood isolates.
  2. 23rd ECCMID Kaku N, Yanagihara K, Harada Y, Migiyama Y, Nagaoka K, Yamada K, Morinaga Y, Hasegawa H, Izumikawa K, Kakeya H and Kohno S: Effect of linezolid on MUC5AC expression induced by methicillin-resistant Staphylococcus aureus in human airway epithelial cells.
  3. 28th International Congress of Chemotherapy and Infection Migiyama Y, Yanagihara K, Kaku N, Harada Y, Yamada K, Nagaoka K, Morinaga Y, Hasegawa H, Izumikawa K, Kakeya H and Kohno S: Pseudomonas aeruginosa bacteremia in immunocompromised and immunocompetent patients; impact of initial antibiotic therap on survival.
  4. 28th International Congress of Chemotherapy and Infection Kaku N, Yanagihara K, Morinaga Y, Harada Y, Migiyama Y, Nagaoka K, Yamada K, Hasegawa H, Izumikawa K, Kakeya H and Kohno S: Effect of linezolid on MUC5AC expression induced by methicillin-resistant Staphylococcus aureus in a human airway epithelial cell.
  5. 28th International Congress of Chemotherapy and Infection Harada Y, Yanagihara K, Kaku N, Migiyama Y, Nagaoka K, Yamada K, Morinaga Y, Hasegawa H, Izumikawa K, Kakeya H and Kohno S: Clinical and molecular epidemiology of ESBL producing Klebsiella pneumoniae and Escherichia coli in a Tertiary Hospital.
  6. 28th International Congress of Chemotherapy and Infection Nagaoka K, Yanagihara K, Harada Y, Yamada K, Migiyama Y, Morinaga Y, Hasegawa H, Izumikawa K, Kakeya H and Kohno S: Prevotella intermedia induce severe bacteremic pneumococcal pneumonia in murine with up-regulating platelet-activating receptor.
  7. 53rd ICAAC Harada Y, Morinaga Y, Kaku N, Akamatsu N, Matsuda J, Uno N, Hasegawa H, Nakamura S, Imamura Y, Izumikawa K, Kohno S and Yanagihara K: In vitro and in vivo activities of piperacillin-tazobactam and meropenem in different inoculum sizes of ESBLKlebsiella pneumoniae.
  8. 28th International Congress of Chemotherapy and Infection Izumikawa K and Kohno S: The management of chronic pulmonary aspergillosis and azole resistance.
  9. 28th International Congress of Chemotherapy and Infection Izumikawa K, Tashiro T, Tashiro M, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Hayashi T, Yanagihara K, Nagayasu T and Kohno S: Pathological and clinical analysis of chronic pulmonary aspergillosis.
  10. 28th International Congress of Chemotherapy and Infection Izumikawa K: Topics of pulmonary aspergillosis.
  11. 18th APSR Izumikawa K: Postgraduate Course 3, Recent Trends and New Insights in Respiratory Infection - Focusing on Epidemiology, Pathogenesis and Treatment- Fungal Infection.
  12. 18th APSR Honda N, Yoshida M, Hirano K, Takazono T, Kosai K, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Tsukamoto M, Izumikawa K, Yanagihara K, Tashiro T and Kohno S: A case of disseminated Mycobacterium avium complex (MAC) infection in a relapsing polychondritis patient.
  13. 28th International Congress of Chemotherapy and Infection Takeda K. Imamura Y, Ide S, Takazono T, Kosai K, Morinaga Y, Nakamura S, Kurihara S, Tsukamoto M, Miyazaki T, Izumikawa K, Yanagihara K, Tashiro T, Kangawa K and Kohno S: Effect of ghrelin for prevention in murine invasive pulmonary aspergillosis model.
  14. 28th International Congress of Chemotherapy and Infection Hirano K, Izumikawa K, Kosai K, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Kakeya H, Yanagihara K, Tashiro T and Kohno S: Efficacy of Antifungal Therapy with Inhaled Azole against Murine Invasive Pulmonary Aspelgillosis with Itraconazole-Low Susceptible Aspergillus fumigatus.
  15. 5th Congress of Asia Pacific Society of Medical Mycology Hirano K, Izumikawa K, Kosai K, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Kakeya H, Yanagihara K, Tashiro T and Kohno S: Efficacy of Inhaled Itraconazole against Murine Invasive Pulmonary Aspergillosis with Itraconazole Low- Susceptible Aspergillus fumigatus.
  16. 53rd ICAAC Hirano K, Izumikawa K, Takazono T, Kosai K, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Kakeya H, Yanagihara K, Tashiro T and Kohno S: Efficacy of Antifungal Therapy with Inhaled Itraconazole against Murine Invasive Pulmonary Aspergillosis with Itraconazole-Low Susceptible Aspergillus fumigatus.
  17. 23rd European Congress of Clinical Microbiology and Infectious Diseases Iwanaga N, Nakamura S, Kajihara T, Tanaka A, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Yanagihara K, Tashiro T and Kohno S: Acquisition of Yersiniabactin production in Klebsiella pneumoniae infection: a risk factor for mortality and influence on clinical outcome.　
  18. 28th International Congress of Chemotherapy and Infection Iwanaga N, Nakamura S, Kajihara T, Tanaka A, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Yanagihara K, Tashiro T, Sunazuka T, Omura S and Kohno S：The potency of a new erythromycin (EM) derivative, EM900, to reduce the density of the nasopharyngeal Streptococcus pneumoniae colonization in mice (poster)
  19. 53rd ICAAC Iwanaga N, Nakamura S, Kajihara T, Takazono T, Imamura Y, Izumikawa K, Yanagihara K, Tashiro T, Sunazuka T, Omura S and Kohno S: The potency of macrolides to promote host innate immunity and reduce the density of the pneumococcal nasopharyngeal colonization in mice.
  20. 28th International Congress of Chemotherapy and Infection Nagayoshi Y, Miyazaki T, Minematsu A, Hosogaya N, Morinaga Y, Nakamura S, Imamura Y, Izumikawa K, Kakeya K, Yanagihara K, Tashiro T, Kohno S: Unexpected effects of the monoamine oxidase A inhibitor clorgyline on antifungal susceptibility of Candida glabrata.